Log in

Relevant bibliographies by topics / KDIGO

Contents

Journal articles
Books
Book chapters
Conference papers

Academic literature on the topic 'KDIGO'

Author: Grafiati

Published: 3 June 2025

Last updated: 31 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'KDIGO.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "KDIGO"

1

Xu, Xiaoqun, Houyong Zhu, Long Cai, Tielong Chen, and Kaiqing Lin. "KDIGO or UACR." Journal of the American College of Cardiology 82, no. 15 (2023): e135-e136. http://dx.doi.org/10.1016/j.jacc.2023.06.051.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Maizel, Julien, Delphine Daubin, Ly Van Vong, et al. "Urinary TIMP2 and IGFBP7 Identifies High Risk Patients of Short-Term Progression from Mild and Moderate to Severe Acute Kidney Injury during Septic Shock: A Prospective Cohort Study." Disease Markers 2019 (April 1, 2019): 1–8. http://dx.doi.org/10.1155/2019/3471215.

Full text

Abstract:

Background. To examine whether the new urinary biomarkers TIMP2 and IGFBP7 can predict progression within 24 hours and 72 hours from mild and moderate (KDIGO 1 or 2) to severe (KDIGO 3) AKI in patients with septic shock. Methods. A prospective, multicenter observational study performed in three French ICUs. The urinary biomarkers TIMP2∗IGFBP7 were analyzed at the early phase (<6 hours) of patients admitted for septic shock with mild and moderate AKI. Results. Among the 112 patients included, 45 (40%) progressed to the KDIGO 3 level 24 hours after inclusion (KDIGO 3 H24) and 47 (42%) 72 hour

APA, Harvard, Vancouver, ISO, and other styles

3

Zeier, M. "KDIGO-Leitlinien zur Nierenlebendspende." Der Nephrologe 14, no. 4 (2019): 295–301. http://dx.doi.org/10.1007/s11560-019-0336-9.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Gross, Horst. "Aktualisierung der KDIGO-Leitlinien." CardioVasc 23, no. 6 (2023): 18–19. http://dx.doi.org/10.1007/s15027-023-3140-4.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Usman, Parveen, Habib Qaisar, Anwar ul Haque, and Qalab Abbas. "COMPARISON OF TWO DEFINITIONS (p-RIFLE AND KDIGO) FOR PREVALENCE OF ACUTE KIDNEY INJURY AND IN HOSPITAL MORTALITY IN A PAEDIATRIC INTENSIVE CARE UNIT OF PAKISTAN." Journal of Ayub Medical College Abbottabad 34, no. 1 (2022): 112–17. http://dx.doi.org/10.55519/jamc-01-9147.

Full text

Abstract:

Background: To compare the Paediatric RIFLE (p-RIFLE) and Kidney Disease Improving Global Outcomes (KDIGO) definitions of acute kidney injury (AKI) for frequency of (AKI) and in-hospital mortality in critically ill children. Methods: Retrospective review of medical records of all patients (aged 1 month – 16 years) admitted in Paediatric Intensive Care Unit from January 2015–December 2016, with length of stay >48 hours, was done. Patients with chronic kidney disease were excluded. Receiver operating characteristic (ROC) curves were used to evaluate the performance of the p-RIFLE and KDIGO cr

APA, Harvard, Vancouver, ISO, and other styles

6

van der Giet, Markus. "KDIGO-Empfehlungen: Praxisnah oder unpraktisch?" MMW - Fortschritte der Medizin 163, no. 6 (2021): 59–61. http://dx.doi.org/10.1007/s15006-021-9707-z.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Ketteler, Markus. "KDIGO-Leitlinien - Knochen- und Mineralstoffwechsel." Dialyse aktuell 14, no. 10 (2010): 564–70. http://dx.doi.org/10.1055/s-0030-1270663.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Zeier, Martin, and Bertram Kasiske. "KDIGO-Leitlinien - Betreuung von Nierentransplantatempfängern." Dialyse aktuell 14, no. 10 (2010): 580–86. http://dx.doi.org/10.1055/s-0030-1270665.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Jadoul, M. "KDIGO et DOPPS : quelles perspectives ?" Néphrologie & Thérapeutique 6, no. 5 (2010): 4–6. http://dx.doi.org/10.1016/s1769-7255(10)70024-9.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

&NA;. "KDIGO to Be Managed Independently." Nephrology Times 5, no. 6 (2012): 7. http://dx.doi.org/10.1097/01.nep.0000415989.64113.f9.

Full text

APA, Harvard, Vancouver, ISO, and other styles

More sources

Books on the topic "KDIGO"

1

Geberth, Steffen. Praxis der Dialyse: 88 Tabellen [nach den Leitlinien NKF KDOQI, KDIGO, EDTA European Best Practice Guidelines (EBPG), DGfN Deutsche Gesellschaft fu r Nephrologie ; mit Transplantationsvorbereitung]. Springer Medizin, 2011.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

2

Herrington, William G., Aron Chakera, and Christopher A. O’Callaghan. Chronic kidney disease. Edited by Patrick Davey and David Sprigings. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780199568741.003.0163.

Full text

Abstract:

Chronic kidney disease (CKD) is defined as abnormalities of kidney structure or function, where the abnormalities have been present for >3 months and have implications for health. It is characterized by a reduced estimated glomerular filtration rate (eGFR) or other renal abnormalities. CKD is staged according to the eGFR or the degree of albuminuria. The KDIGO (Kidney Disease: Improving Global Outcomes) criteria for CKD is either an eGFR that is <60 ml/min 1.73 m−2 and has been present for >3 months, or one or more markers of kidney damage, when these have been present for >3 month

APA, Harvard, Vancouver, ISO, and other styles

3

Upadhyay, Ashish, Lesley A. Inker, and Andrew S. Levey. Chronic kidney disease. Edited by David J. Goldsmith. Oxford University Press, 2015. http://dx.doi.org/10.1093/med/9780199592548.003.0094.

Full text

Abstract:

The conceptual model, definition, and classification of chronic kidney disease (CKD) were first described in the National Kidney Foundation’s Kidney Disease Outcomes Quality Initiative (KDOQI) guidelines in 2002 and have had a major impact on patient care and research. Since this publication there has been an increased recognition that the cause of CKD influences progression and complications. In addition, epidemiologic reports from diverse populations have consistently shown graded relations between higher albuminuria and adverse kidney outcomes and complications, in addition to, and independ

APA, Harvard, Vancouver, ISO, and other styles

4

Niaudet, Patrick, and Alain Meyrier. Minimal change disease. Edited by Neil Turner. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780199592548.003.0056_update_001.

Full text

Abstract:

Minimal change disease is characteristically responsive to high-dose corticosteroids. As this is the most common cause of nephrotic syndrome in children, and responses are usually prompt, response to 60 mg/m2/day of oral prednisolone (max. 80 mg) is often used as a diagnostic test. Adults respond more slowly and have a wider differential diagnosis, and often a high risk of side effects, so therapy is not recommended without confirmation by renal biopsy. Then first-line treatment is again prednisolone or prednisone, at 1 mg/kg/day (max. 60 mg). KDIGO and other treatment protocols recommend 6 we

APA, Harvard, Vancouver, ISO, and other styles

5

Sprague, Stuart M., and James M. Pullman. Spectrum of bone pathologies in chronic kidney disease. Edited by David J. Goldsmith. Oxford University Press, 2015. http://dx.doi.org/10.1093/med/9780199592548.003.0122.

Full text

Abstract:

Histologic bone abnormalities begin very early in the course of chronic kidney disease. The KDIGO guidelines recommend that bone disease in patients with chronic kidney disease should be diagnosed on the basis of bone biopsy examination, with bone histomorphometry. They have also proposed a new classification system (TMV), using three key features of bone histology—turnover, mineralization, and volume—to describe bone disease in these patients. However, bone biopsy is still rarely performed today, as it involves an invasive procedure and highly specialized laboratory techniques. High-turnover

APA, Harvard, Vancouver, ISO, and other styles

6

Hoste, Eric A. J., John A. Kellum, and Norbert Lameire. Definitions, classification, epidemiology, and risk factors of acute kidney injury. Edited by Norbert Lameire. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780199592548.003.0220_update_001.

Full text

Abstract:

The lack of a precise biochemical definition of acute kidney injury (AKI) resulted in at least 35 definitions in the medical literature, which gave rise to a wide variation in reported incidence and clinical significance of AKI, impeded a meaningful comparison of studies.The first part of this chapter describes and discusses different definitions and classification systems of AKI. Patient outcome and the need for renal replacement therapy are directly related to the severity of AKI, an observation that supports the use of a categorical staging system rather than a simple binary descriptor. The

APA, Harvard, Vancouver, ISO, and other styles

7

Jadoul, Michel, Laura Labriola, and Eric Goffin. Viral infections in patients on dialysis. Edited by Jonathan Himmelfarb. Oxford University Press, 2015. http://dx.doi.org/10.1093/med/9780199592548.003.0271.

Full text

Abstract:

From the early days of hemodialysis, viral hepatitis has been recognized as common in dialyzed patients.The prevalence and incidence of HBV infection have decreased markedly over the last decades in HD units. Still, the infectivity of HBV is very high. Vaccinating HD patients, preferably prior to starting dialysis, together with the strict application of hygienic precautions and adequate screening of blood donors remains required, together with the segregation of infective (HBV+) patients in a separate dialysis ward. The level of aminotransferases is markedly lower in HD patients than in the g

APA, Harvard, Vancouver, ISO, and other styles

8

Bardin, Thomas, and Tilman Drüeke. Renal osteodystrophy. Oxford University Press, 2013. http://dx.doi.org/10.1093/med/9780199642489.003.0149.

Full text

Abstract:

Renal osteodystrophy (ROD) is a term that encompasses the various consequences of chronic kidney disease (CKD) for the bone. It has been divided into several entities based on bone histomorphometry observations. ROD is accompanied by several abnormalities of mineral metabolism: abnormal levels of serum calcium, phosphorus, parathyroid hormone (PTH), vitamin D metabolites, alkaline phosphatases, fibroblast growth factor-23 (FGF-23) and klotho, which all have been identified as cardiovascular risk factors in patients with CKD. ROD can presently be schematically divided into three main types by h

APA, Harvard, Vancouver, ISO, and other styles

Book chapters on the topic "KDIGO"

1

Ramachandran, Raja, and Vivekanand Jha. "Integration with Kidney Disease Improving Global Outcomes (KDIGO)." In Glomerulonephritis. Springer International Publishing, 2019. http://dx.doi.org/10.1007/978-3-319-49379-4_6.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Ramachandran, Raja, and Vivekanand Jha. "Integration with Kidney Disease Improving Global Outcomes (KDIGO)." In Glomerulonephritis. Springer International Publishing, 2018. http://dx.doi.org/10.1007/978-3-319-27334-1_6-1.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Takahashi, Kazuo, Ryohei Yamamoto, and Yukio Yuzawa. "Japanese Clinical Practice Guidelines for IgA Nephropathy: Difference from KDIGO Guidelines." In Pathogenesis and Treatment in IgA Nephropathy. Springer Japan, 2016. http://dx.doi.org/10.1007/978-4-431-55588-9_15.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Li, Philip Kam-tao, and Kai Ming Chow. "The Implication of the KDIGO Clinical Practice Guidelines on Management of IgA Nephropathy." In Pathogenesis and Treatment in IgA Nephropathy. Springer Japan, 2016. http://dx.doi.org/10.1007/978-4-431-55588-9_14.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Dong, Huachao, Peng Wang, and Jinglu Li. "KDGO." In Data-Driven Global Optimization Methods and Applications. CRC Press, 2025. https://doi.org/10.1201/9781003636267-10.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Malik, Shafi. "Glomerulonephritis, Tubulointerstitial Nephritis, and Vasculitis." In Best of Five MCQs for the European Specialty Examination in Nephrology. Oxford University PressOxford, 2023. http://dx.doi.org/10.1093/oso/9780192844163.003.0001.

Full text

Abstract:

Abstract This chapter focuses on multisystem disorders that involve the kidney such as vasculitis and systemic lupus. Often these conditions are influenced by immune-mediated pathways, and an understanding of the basic science involved helps guide management. Questions test areas of factual knowledge such as biopsy findings and recent trial evidence, as well as problem-solving in vasculitis and glomerulonephritis clinical scenarios. Familiarity with international guidelines, such as Kidney Disease: Improving Global Outcomes (KDIGO) and European Alliance of Associations for Rheumatology (EULAR)

APA, Harvard, Vancouver, ISO, and other styles

7

Robert, Laurine, Chloé Rousseliere, Jean-Baptiste Beuscart, et al. "Integration of Explicit Criteria in a Clinical Decision Support System Through Evaluation of Acute Kidney Injury Events." In Studies in Health Technology and Informatics. IOS Press, 2021. http://dx.doi.org/10.3233/shti210249.

Full text

Abstract:

In Clinical Decision Support System (CDSS), relevance of alerts is essential to limit alert fatigue and risk of overriding relevant alerts by health professionals. Detection of acute kidney injury (AKI) situations is of great importance in clinical practice and could improve quality of care. Nevertheless, to our knowledge, no explicit rule has been created to detect AKI situations in CDSS. The objective of the study was to implement an AKI detection rule based on KDIGO criteria in a CDSS and to optimize this rule to increase its relevance in clinical pharmacy use. Two explicit rules were imple

APA, Harvard, Vancouver, ISO, and other styles

8

Lima, Sanderlan Silva de, and Renata Plech de Amorim. "INSUFICIÊNCIA RENAL AGUDA." In MANUAL DE EMERGÊNCIAS PEDIÁTRICAS. Hawking, 2023. http://dx.doi.org/10.29327/5293834.1-16.

Full text

Abstract:

A Insuficiência Renal Aguda (IRA) é uma das doenças renais que afetam a função e estrutura renal (KDIGO, 2012). É definida pelo aumento súbito da creatinina sérica e/ou diminuição do débito urinário, as custas da redução da taxa de filtração glomerular (TFG) e da capacidade de excretar resíduos nitrogenados e regular o volume extracelular e eletrólitos (MOHRER, 2017). A IRA é um problema de saúde crescente entre as crianças, com maior incidência entre as hospitalizadas ou em unidade de terapia intensiva (UTI), devido a sua etiologia multifatorial com condições renais específicas, não específic

APA, Harvard, Vancouver, ISO, and other styles

9

Lee, Kyung Hyun, Sangchul Hahn, Hyunsun Lim, Ki-Byung Lee, and Yong Kyu Lee. "Development of Labeling Algorithm for Early Prediction of Acute Kidney Injury." In Studies in Health Technology and Informatics. IOS Press, 2025. https://doi.org/10.3233/shti250415.

Full text

Abstract:

Acute kidney injury is a prevalent and severe complication in hospitalized patients, contributing to increased morbidity and mortality. While numerous predictive models exist, they primarily focus on identifying AKI after its onset rather than forecasting it in advance. We developed a labeling algorithm to capture the earliest onset time of in-hospital AKI based on KDIGO 2012 criteria to address this limitation. We retrospectively analyzed 143,512 in-hospital cases from National Health Insurance Service Ilsan Hospital between 2015 and 2021, applying the algorithm to capture the earliest AKI on

APA, Harvard, Vancouver, ISO, and other styles

10

Malik, Shafi. "Cardiovascular Disease, Hypertension, and Diabetes (Part A)." In Best of Five MCQs for the European Specialty Examination in Nephrology. Oxford University PressOxford, 2023. http://dx.doi.org/10.1093/oso/9780192844163.003.0006.

Full text

Abstract:

Abstract Diabetes currently affects 8% of the world’s population and this is projected to increase to 12% by the middle of the century. Of those patients with diabetes, around 40% will develop chronic kidney disease and approximately 20% with diabetic kidney disease will progress to end-stage renal disease. SGLT-2 inhibitors, have not only shown efficacy in improving glycaemic control and cardiovascular outcomes, but also demonstrated a reduction in hard renal endpoints. Data from two large randomized controlled trials, CREDENCE and the recently published DAPA-CKD, showed a reduced risk of CKD

APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "KDIGO"

1

Uboltham, Issariya, Nakornthip Prompoon, and Wirichada Pan-ngum. "AKIHelper: Acute kidney injury diagnostic tool using KDIGO guideline approach." In 2016 IEEE/ACIS 15th International Conference on Computer and Information Science (ICIS). IEEE, 2016. http://dx.doi.org/10.1109/icis.2016.7550749.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Surducan, Mihai. "Preview of the new KDIGO Guidelines for ADPKD, available later in 2024." In 61st ERA Congress, edited by Rachel Giles. Medicom Medical Publishers, 2024. http://dx.doi.org/10.55788/6737c5fd.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Li, Bo, Jingkun Mao, and Guanggang Li. "Clustering Analysis of Patients Kdigo Scoring Time Series Data Based on DTW Algorithm." In 2023 42nd Chinese Control Conference (CCC). IEEE, 2023. http://dx.doi.org/10.23919/ccc58697.2023.10239757.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Martinelli, Betânia Carvalho, Isadora Lamberti Elvira, and Tufik José Magalhães Geleilete. "Evolution of glomerular filtration rate in patients with chronic kidney disease." In III SEVEN INTERNATIONAL MULTIDISCIPLINARY CONGRESS. Seven Congress, 2023. http://dx.doi.org/10.56238/seveniiimulti2023-080.

Full text

Abstract:

Chronic kidney disease (CKD) can be both a microvascular complication of diabetes mellitus (DM) and systemic arterial hypertension (SAH). DM, SAH and CKD are independent risk factors for cardiovascular disease. The presence of a high albumin/creatinine ratio and a sustained reduction in glomerular filtration rate (GFR) clinically identify CKD. The Kidney Disease Improving Global Outcomes (KDIGO) guidelines recommend an HbA1c target of around 7.0% to prevent or delay the progression of microvascular complications of diabetes [Alicic R.Z. et al, 2017], as well as keeping systolic blood pressure

APA, Harvard, Vancouver, ISO, and other styles

5

Schmid, N., M. Ghinescu, M. Schanz, et al. "Algorithm-Based Detection of Acute Kidney Injury According to Full KDIGO Criteria Including Urine Output following Cardiac Surgery: A Descriptive Analysis." In 52nd Annual Meeting of the German Society for Thoracic and Cardiovascular Surgery (DGTHG). Georg Thieme Verlag KG, 2023. http://dx.doi.org/10.1055/s-0043-1761716.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Tavares Pereira Monteiro, Maria, Laura Paes Moraes, Daniel Tavares Peres, and Márcia Valéria Azeredo Gomes de Carvalho. "Incidência de Injúria Renal Aguda em pacientes com COVID-19 internados em Unidades de Terapia Intensiva na cidade de Campos dos Goytacazes, RJ." In Semana Científica da Faculdade de Medicina de Campos. Faculdade de Medicina de Campos, 2022. http://dx.doi.org/10.29184/anaisscfmc.v12022p12.

Full text

Abstract:

Introdução: O ano de 2020 foi marcado por uma pandemia global resultado da transmissão do novo coronavírus causador da síndrome respiratória aguda grave 2 (SARS-CoV-2) e causador da doença COVID-19. O acometimento respiratório apresenta maior evidência, entretanto, essa patologia pode causar comprometimento em diversos sistemas do corpo humano. Objetivos: O presente estudo determinou a incidência do surgimento de Injúria Renal Aguda (IRA) secundária ao COVID-19 em pacientes internados em Unidades de Terapia Intensiva (UTI) de hospitais públicos da cidade de Campos dos Goytacazes-RJ. Métodos:

APA, Harvard, Vancouver, ISO, and other styles

7

Lamounier, TCRL, PF Távora, J. Resende Neto, MMR Gomes, and LI Santos. "AVALIAÇÃO DO DESEMPENHO ANALÍTICO E CLÍNICO DO EQUIPAMENTO EPOC® POINT OF CARE EM COMPARAÇÃO COM A GASOMETRIA PADRÃO EM DOENTES COM NEFROPATIA." In Resumos do 55º Congresso Brasileiro de Patologia Clínica/Medicina Laboratorial. Zeppelini Editorial e Comunicação, 2023. http://dx.doi.org/10.5327/1516-3180.141s2.8264.

Full text

Abstract:

Objetivo: Este estudo teve como objetivo avaliar o desempenho da plataforma Siemens Healthineers Epoc® para a quantificação de parâmetros gasométricos, glicose, creatinina, íons, hemoglobina e hematócrito, comparando esse equipamento com a metodologia de referência para gasometria em pacientes com DRC. Método: Oitenta e cinco amostras de sangue obtidas de pacientes em acompanhamento clínico com nefrologistas foram coletadas e processadas no Epoc® e comparadas com a plataforma RapidPoint®500e Siemens Healthineers; a creatinina foi comparada com a plataforma Abbott Architect®. Discrepâncias rela

APA, Harvard, Vancouver, ISO, and other styles

8

Moutinho, Leonardo, Bruna Leticia de Albuquerque Correa, Veronica Direito Souza Poletti Santos, and Cristiano Henrique Batista de Oliveira. "Análise do perfil de resultados de eTFG em laboratório de apoio." In Resumos do 56º Congresso Brasileiro de Patologia Clínica/Medicina Laboratorial. Zeppelini Editorial e Comunicação, 2024. https://doi.org/10.5327/1516-3180.142s1.12437.

Full text

Abstract:

Objetivo: A doença renal crônica é umas das principais consequências da diminuição ou insuficiência da função renal. O exame clínico padrão capaz de detectar e estimar o funcionamento renal se dá por meio de cálculos da taxa de filtração glomerular (eTFG) por meio da medição da creatininasérica. No Brasil, a recomendação é liberar a eTFG tanto para não negro quanto para negro no mesmo laudo. O objetivo do trabalho foi avaliar o perfil da eTFG em pacientes adultos atendidos em um laboratório de apoio de Belo Horizonte, Minas Gerais. Método: Foi realizado o levantamento de dados de 123 amostras

APA, Harvard, Vancouver, ISO, and other styles

9

Vavić, Neven, Jelena Tadić, and Katarina Obrenčević. "Use of SGLT2i after kidney transplantation, first experiences." In 7th International Congress of Cardionephrology KARNEF 2025. Punta Niš, 2025. https://doi.org/10.46793/karnef25.165v.

Full text

Abstract:

Recent large randomized trials have demonstrated the benefit of sodium-glucose cotransporter-2 inhibitors (SGLT2i) in improving renal and CV outcomes in patients (pc) with chronic kidney disease. According to the new KDIGO guidelines, SGLT2i are the first choice of treatment for diabetics with chronic kidney disease (CKD), but also for other pc with CKD and pc with heart failure with or without diabetes (DM). However, there is insufficient data on the efficacy and safety of SGLT2i administration in pc after renal transplantation (KTP) with or without DM, since, due to safety concerns, these PC

APA, Harvard, Vancouver, ISO, and other styles

10

Rossato, BG, CS Stein, JAM Carvalho, MMMF Duarte, and RN Moresco. "ASSOCIAÇÃO ENTRE CONCENTRAÇÕES URINÁRIAS DE NGAL E RISCO DE DOENÇA RENAL CRÔNICA EM PACIENTES COM DIABETES TIPO 2." In Resumos do 54º Congresso Brasileiro de Patologia Clínica/Medicina Laboratorial. Zeppelini Editorial e Comunicação, 2022. http://dx.doi.org/10.5327/1516-3180.140s1.5481.

Full text

Abstract:

Objetivo: Investigar a associação entre as concentrações urinárias de lipocalina associada à gelatinase de neutrófilos (NGAL) e o risco de desenvolvimento de doença renal crônica (DRC) em pacientes portadores de diabetes mellitus tipo 2 (DM2). Método: Sessenta e nove pacientes diagnosticados com DM2 foram estratificados quanto ao risco de DRC de acordo com os critérios do Kidney Disease: Improving Global Outcomes (KDIGO), que leva em consideração os resultados de albumina urinária (Albu) e a taxa de filtração glomerular (TFG). A TFG foi estimada pela equação CKD-EPI, e a albumina urinária foi

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!